BackDNA Print Genomics Overview

DNA Print Genomics Total Liabilities

DNA Print Genomics's total liabilities is $11M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$11.50M
10.24% YoYΔ $1.07M vs prior year quarter

Peer trimmed avg / median

Loading

DNA Print Genomics Total Liabilities History

Loading

DNA Print Genomics vs. peers: Total Liabilities Comparison

Loading

DNA Print Genomics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DNA Print Genomics (DNAG) FAQ

As of the most recent data (September 2007), DNAG shows a total liabilities of $11M. That compares with $10M in the prior-year period — up 10.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DNAG's total liabilities is now $11M (was $10M) — a 10.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether DNA Print Genomics is outperforming or lagging.

Tracking DNAG's total liabilities over time shows whether DNA Print Genomics is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $10M in the prior-year period — up 10.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has DNA Print Genomics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $11M) with ownership activity and broader fundamentals.

DNA Print Genomics's total liabilities is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.